# Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation

Study · id `cardio:ct-nct04687111` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04687111](<https://clinicaltrials.gov/study/NCT04687111>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04687111

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: High blood pressure; Heart failure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 250 participants.

## Technical summary

Registry record NCT04687111. Randomized; quadruple masking; primary purpose prevention. Start 2015-12-16 (actual); primary completion 2021-06-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 2
- Enrolled: 250 participants (enrolled count; ClinicalTrials.gov record NCT04687111, source copy `cardio:ctgov-nct04687111-2021-05-11`, retrieved 2026-10-26)
- Started: 2015-12-16 (actual) (ClinicalTrials.gov record NCT04687111, source copy `cardio:ctgov-nct04687111-2021-05-11`, retrieved 2026-10-26)
- Primary completion: 2021-06-11 (anticipated) (ClinicalTrials.gov record NCT04687111, source copy `cardio:ctgov-nct04687111-2021-05-11`, retrieved 2026-10-26)
- Completion: 2021-06-11 (anticipated) (ClinicalTrials.gov record NCT04687111, source copy `cardio:ctgov-nct04687111-2021-05-11`, retrieved 2026-10-26)
- Countries: Ireland (ClinicalTrials.gov record NCT04687111, source copy `cardio:ctgov-nct04687111-2021-05-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04687111-2021-05-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation
- Acronym: PARABLE
- Condition: Atrial Remodeling
- Condition: Myocardial Dysfunction
- Condition: Left Ventricular Remodeling
- Condition: Left Ventricular Diastolic Dysfunction
- Condition: Hypertension
- Condition: Cardiovascular Morbidity
- Condition: Fibrosis Myocardial
- Condition: Inflammatory Myopathy
- Condition: Atrial Arrhythmia
- Intervention (Drug): Sacubitril-Valsartan
- Intervention (Drug): Valsartan
- Lead sponsor: Mark Ledwidge
- Lead sponsor class: OTHER
- Collaborator: The Heartbeat Trust
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Cardiomyopathy (heart muscle disease) (`cardio:cardiomyopathy`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record: Valsartan (`cardio:valsartan`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Sacubitril/Valsartan vs Valsartan on Left Atrial Volume in Patients With Pre-Heart Failure With Preserved Ejection Fraction: The PARABLE Randomized Clinical Trial (`cardio:pubmed-36884247`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Cine-derived mitral annular relaxation velocity for detection of preclinical left ventricular diastolic dysfunction (`cardio:pubmed-42349572`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: fc78a278be92451690eec7183e645185349b4e9cb00f7a79a1ce42b150ebb7cb
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
